These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Repopulation of host lymphohematopoietic systems by donor cells during graft-versus-host reaction in unirradiated adult F1 mice injected with parental lymphocytes. Hakim FT; Sharrow SO; Payne S; Shearer GM J Immunol; 1991 Apr; 146(7):2108-15. PubMed ID: 1672343 [TBL] [Abstract][Full Text] [Related]
4. Mls-1a-induced peripheral tolerance to host minor histocompatibility antigens in radiation bone marrow chimeras. Modification of T cell repertoire associated with active suppression and permanent presentation of host antigens. Miconnet I; Bruley-Rosset M; Halle-Pannenko O J Immunol; 1992 Jun; 148(12):3706-13. PubMed ID: 1534822 [TBL] [Abstract][Full Text] [Related]
5. Role of L3T4+ and Lyt-2+ donor cells in graft-versus-host immune deficiency induced across a class I, class II, or whole H-2 difference. Moser M; Sharrow SO; Shearer GM J Immunol; 1988 Apr; 140(8):2600-8. PubMed ID: 3258615 [TBL] [Abstract][Full Text] [Related]
6. [The influence of subclinical level of graft versus host reaction on reconstitution of host lymphoid tissues]. Hirano M Hokkaido Igaku Zasshi; 1994 May; 69(3):453-65. PubMed ID: 7927174 [TBL] [Abstract][Full Text] [Related]
7. Specific destruction of host-reactive mature T cells of donor origin prevents graft-versus-host disease in cyclophosphamide-induced tolerant mice. Eto M; Mayumi H; Tomita Y; Yoshikai Y; Nishimura Y; Maeda T; Ando T; Nomoto K J Immunol; 1991 Mar; 146(5):1402-9. PubMed ID: 1671578 [TBL] [Abstract][Full Text] [Related]
8. Murine recipients of fully mismatched donor marrow are protected from lethal graft-versus-host disease by the in vivo administration of rapamycin but develop an autoimmune-like syndrome. Blazar BR; Taylor PA; Snover DC; Sehgal SN; Vallera DA J Immunol; 1993 Nov; 151(10):5726-41. PubMed ID: 8228258 [TBL] [Abstract][Full Text] [Related]
9. Immune dysfunction associated with graft-vs-host reaction in mice transplanted across minor histocompatibility barriers. II. Reversible defect in T-dependent antibody responses. Budhecha S; Hamilton BL J Immunol; 1989 Jun; 142(11):3740-5. PubMed ID: 2523932 [TBL] [Abstract][Full Text] [Related]
10. Activation of CD4+ and CD8+ lymphocyte subsets by streptozotocin in the popliteal lymph node assay. II. Comparison with acute graft-vs-host reaction in H-2 incompatible F1 mouse hybrids. Krzystyniak K; Panaye G; Descotes J; Revillard JP Immunopharmacol Immunotoxicol; 1992; 14(4):865-82. PubMed ID: 1363474 [TBL] [Abstract][Full Text] [Related]
11. Unexpected role of TNF-alpha in graft versus host reaction (GVHR): donor-derived TNF-alpha suppresses GVHR via inhibition of IFN-gamma-dependent donor type-1 immunity. Yamamoto S; Tsuji T; Matsuzaki J; Zhange Y; Chamoto K; Kosaka A; Togashi Y; Sekikawa K; Sawada K; Takeshima T; Koike T; Nishimura T Int Immunol; 2004 Jun; 16(6):811-7. PubMed ID: 15126416 [TBL] [Abstract][Full Text] [Related]
12. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease. Drobyski WR; Majewski D; Hanson G Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102 [TBL] [Abstract][Full Text] [Related]
13. Modulation of F1 cytotoxic potentials by GvHR. Host- and donor-derived cytotoxic lymphocytes arise in the unirradiated F1 host spleens under the condition of GvHR-associated immunosuppression. Kubota E; Ishikawa H; Saito K J Immunol; 1983 Sep; 131(3):1142-8. PubMed ID: 6604089 [TBL] [Abstract][Full Text] [Related]
14. Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a nonmyeloablative regimen. Tomita Y; Khan A; Sykes M J Immunol; 1994 Aug; 153(3):1087-98. PubMed ID: 8027542 [TBL] [Abstract][Full Text] [Related]
15. Regulation of graft-versus-host-reaction by Mlsa-reactive donor T cells. Muluk SC; Hakim FT; Shearer GM Eur J Immunol; 1992 Aug; 22(8):1967-73. PubMed ID: 1639099 [TBL] [Abstract][Full Text] [Related]
16. Immunosuppressive activity of macrophages in mice undergoing graft-versus-host reaction due to major histocompatibility complex class I plus II difference. Ikarashi Y; Kawai K; Watanabe H; Matsumoto Y; Omata S; Fujiwara M Immunology; 1993 May; 79(1):95-102. PubMed ID: 8099568 [TBL] [Abstract][Full Text] [Related]
17. Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease. Johnson BD; Drobyski WR; Truitt RL Bone Marrow Transplant; 1993 Apr; 11(4):329-36. PubMed ID: 8485480 [TBL] [Abstract][Full Text] [Related]
18. Alloreactive lymphocytes from T cell receptor (beta-chain) transgenic mice do not mediate a graft-versus-host reaction. Rimm IJ; Ghayur T; Gasser DL; Rosenkrantz K; Burakoff SJ; Seidman JG; Ferrara JL J Immunol; 1991 Feb; 146(4):1130-3. PubMed ID: 1825104 [TBL] [Abstract][Full Text] [Related]
19. [A study on clonal elimination of auto-reactive thymocytes in bone marrow chimera mice]. Arase N Hokkaido Igaku Zasshi; 1992 May; 67(3):308-21. PubMed ID: 1511955 [TBL] [Abstract][Full Text] [Related]
20. Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy. Johnson BD; Becker EE; LaBelle JL; Truitt RL J Immunol; 1999 Dec; 163(12):6479-87. PubMed ID: 10586039 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]